Morphocell Technologies
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $50M
Investors
- 3
About Morphocell Technologies
Founded in 2018 in Laval, Canada, Morphocell Technologies specializes in innovative approaches to tissue engineering for liver health.Morphocell Technologies specializes in advanced tissue engineering, focusing on innovative solutions for liver diseases. Their core product, ReLiver®, is designed to deliver effective treatments for severe liver conditions through engineered tissues that aim to replicate the functions of healthy liver cells. The technology is intended for use in both adult and pediatric populations, addressing critical medical needs for patients suffering from liver dysfunction. The company actively collaborates with research institutions and other organizations, such as CQDM and the Stem Cell Network, to develop regenerative therapies for pediatric urea cycle disorders. The company’s revenue structure is grounded in business-to-business arrangements, primarily involving partnerships with healthcare institutions and pharmaceutical companies. Through these collaborations, Morphocell supplies its flagship product, ReLiver®, as part of clinical trials or therapeutic applications in hospital settings. Transactions may occur through direct partnerships or licensing agreements, enabling healthcare providers to integrate Morphocell's engineered tissues into their treatment protocols. The company plans to explore new markets in Europe, aiming to launch its products in additional regions by 2026, facilitating broader access to its innovative therapies for liver diseases.
Who invested in Morphocell Technologies
3 investors across 2 rounds
See all investors in Morphocell Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Morphocell Technologies
Who invested in Morphocell Technologies?
Morphocell Technologies has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Morphocell Technologies raised?
Morphocell Technologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Morphocell Technologies last raise money?
Morphocell Technologies's most recent round on record is a Series A, in Dec 2025.
What does Morphocell Technologies do?
Founded in 2018 in Laval, Canada, Morphocell Technologies specializes in innovative approaches to tissue engineering for liver health.
Where is Morphocell Technologies headquartered?
Morphocell Technologies is headquartered in Laval, Canada.
Which VCs invest in companies like Morphocell Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back companies at Morphocell Technologies's stage. Their profiles are linked below.
VCs to look at next
Raising like Morphocell Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.